The notices it replaced
- Reissues: PAR-21-064 NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
- 2 steps back: PAR-18-340 NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01-Clinical Trial Required)
- 3 steps back: PAR-15-116 NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)
- 4 steps back: PAR-12-123 NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)
Replaced by PAR-25-343.
Who won it before
19 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $15,086,725 in first-year total cost, median $837,287.
Most frequent study sections
- Special Emphasis Panel[ZDC1 SRB-L (49)]2
- Special Emphasis Panel[ZDC1 SRB-L (50)]2
- Special Emphasis Panel[ZDC1 SRB-X (61)]2
- Special Emphasis Panel[ZDC1 SRB-E (26)]1
- Special Emphasis Panel[ZDC1 SRB-E (29)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY3
- WASHINGTON UNIVERSITY2
- BROWN UNIVERSITY1
- EMORY UNIVERSITY1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Transcranial Direct Current Stimulation to Treat Aphasia: A Superiority Study1U01DC022447-01A1 | BONILHA, LEONARDO FFRIDRIKSSON, JULIUS | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $1,202,905 | ZDC1 |
| 2023 | Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients1U01DC020452-01A1 · under PAR-21-064 | SABA, NABIL FSCHMITT, NICOLE CHERIE | EMORY UNIVERSITY, GA | $585,829 | ZDC1 |
| 2022 | Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection1U01DC020175-01 · under PAR-21-064 | RUBEL, EDWIN WWINTHROP, KEVIN LORING | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $657,906 | ZDC1 |
| 2021 | A Pilot Clinical Trial for Speech Neuroprosthesis1U01DC018671-01A1 · under PAR-18-340 | CHANG, EDWARD | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,158,067 | ZDC1 |
| 2021 | Single-neuron population dynamics in human speech motor cortex for a speech prosthesis1U01DC019430-01 · under PAR-18-340 | HENDERSON, JAIMIE MSHENOY, KRISHNA V | STANFORD UNIVERSITY, CA | $1,050,840 | ZDC1 |
| 2021 | Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction1U01DC019364-01 · under PAR-18-340 | DELLA SANTINA, CHARLES C | JOHNS HOPKINS UNIVERSITY, MD | $597,201 | ZDC1 |
| 2020 | Clinical Utility of Residual Hearing in the Cochlear Implant Ear1U01DC018920-01 · under PAR-18-340 | ADUNKA, OLIVER FRANZORTMANN, AMANDA JUDITH | OHIO STATE UNIVERSITY, OH | $921,686 | ZDC1 |
| 2020 | Cochlear Implantation in Children with Asymmetric Hearing Loss or Single Sided Deafness Clinical Trial1U01DC018942-01 · under PAR-18-340 | FIRSZT, JILL B | WASHINGTON UNIVERSITY, MO | $880,058 | ZDC1 |
| 2019 | Speech Entrainment for Aphasia Recovery (SpARc)1U01DC017521-01A1 · under PAR-18-340 | BONILHA, LEONARDO FFRIDRIKSSON, JULIUS | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $849,696 | ZDC1 |
| 2019 | Intuitive, complete neural control of tablet computers for communication1U01DC017844-01 · under PAR-18-340 | HOCHBERG, LEIGH R | BROWN UNIVERSITY, RI | $837,287 | ZDC1 |
| 2018 | Maximizing outcomes for preschoolers with developmental language disorder: testing the effects of a sequentially targeted naturalistic intervention1U01DC017135-01 · under PAR-15-116 | HADLEY, PAMELA AKAISER, ANN P.ROBERTS, MEGAN Y | VANDERBILT UNIVERSITY, TN | $1,237,542 | ZDC1 |
| 2018 | Diet-induced modification of sweet taste perception and preference: A potential strategy to aid in population-wide reduction in sugar intake1U01DC017130-01 · under PAR-15-116 | BEAUCHAMP, GARY KWISE, PAUL M | MONELL CHEMICAL SENSES CENTER, PA | $566,924 | ZDC1 |
| 2017 | COCHLEAR IMPLANTATION IN ADULTS WITH ASYMMETRIC HEARING LOSS CLINICAL TRIAL1U01DC014938-01A1 · under PAR-15-116 | FIRSZT, JILL B | WASHINGTON UNIVERSITY, MO | $676,487 | ZDC1 |
| 2015 | Efficacy of Tympanostomy Tubes for Children with Recurrent Acute Otitis Media1U01DC013995-01A1 · under PAR-12-123 | HOBERMAN, ALEJANDROPRECIADO, DIEGO | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $967,885 | ZDC1 |
| 2015 | Tinnitus Retraining Therapy Trial (TRTT)2U01DC007411-06 · under PAR-12-123 | FORMBY, CHARLES CRAIG | UNIVERSITY OF ALABAMA IN TUSCALOOSA, AL | $350,000 | ZDC1 |
| 2015 | Tinnitus Retraining Therapy Trial2U01DC007422-06 · under PAR-12-123 | SCHERER, ROBERTA W | JOHNS HOPKINS UNIVERSITY, MD | $182,116 | ZDC1 |
| 2014 | AVERT_Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage1U01DC013778-01A1 · under PAR-12-123 | NEWMAN-TOKER, DAVID | JOHNS HOPKINS UNIVERSITY, MD | $1,163,935 | ZDC1 |
| 2014 | A Phase II Trial on Rizatriptan for Vestibular Migraine1U01DC013256-01A1 · under PAR-12-123 | BALOH, ROBERT WILLIAMSTAAB, JEFFREY PAUL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $658,484 | ZDC1 |
| 2014 | Phase I safety study for a new two-shank auditory midbrain implant (AMI)1U01DC013030-01A1 · under PAR-12-123 | LENARZ, THOMASLIM, HUBERT HYUNGILPATRICK, JAMES FINLAY | UNIVERSITY OF MINNESOTA, MN | $541,877 | ZDC1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.